| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/05/2007 | US20070077617 Polypeptide cleavage method using ompt protease variant |
| 04/05/2007 | US20070077592 Hemipteran glutamate decarboxylase |
| 04/05/2007 | US20070077591 Novel polypeptide |
| 04/05/2007 | US20070077574 Fusion proteins; SARP genes/proteins; for treatment of cancer, diseases related to the regulation of SARP expression in tissue and bodily fluid samples, including cancers; monoclonal/polyclonal antibodies |
| 04/05/2007 | US20070077569 Transgenic cell which produces sucrose isomerases for use in generation of isomaltulose from sucrose; sugar substitute |
| 04/05/2007 | US20070077251 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 04/05/2007 | US20070077250 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 04/05/2007 | US20070077249 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 04/05/2007 | US20070077248 Tumour necrosis factor binding ligands |
| 04/05/2007 | US20070077247 Receptor on the surface of activated T-cells: ACT-4 |
| 04/05/2007 | US20070077246 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/05/2007 | US20070077245 NOTCH mutations leading to increased receptor signaling |
| 04/05/2007 | US20070077244 Inhibitor protein of the wnt signal pathway |
| 04/05/2007 | US20070077242 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 04/05/2007 | US20070077229 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin |
| 04/05/2007 | US20070077227 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition |
| 04/05/2007 | US20070077199 Humanized collagen antibodies and related methods |
| 04/05/2007 | CA2623624A1 Variants of the lantibiotic mersacidin and their use |
| 04/05/2007 | CA2623547A1 Method for amidating polypeptides with basic aminoacid c-terminals by means of specific endoproteases |
| 04/05/2007 | CA2621623A1 Il-17a and il-17f antagonists and methods of using the same |
| 04/04/2007 | EP1770397A1 Procalcitonin 3-116 |
| 04/04/2007 | EP1770164A2 Streptococcus pneumoniae antigens and vaccines |
| 04/04/2007 | EP1770163A2 Antagonists of interleukin-15 |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770160A1 Monocyte-derived nucleic acids and related compositions and methods |
| 04/04/2007 | EP1770101A1 Antibodies against caspase-8, their preparation and use |
| 04/04/2007 | EP1770100A2 Transferrin receptor genes of Moraxella |
| 04/04/2007 | EP1769070A2 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 04/04/2007 | EP1769001A2 Methods of detecting a phenotype of a polymorphic protein |
| 04/04/2007 | EP1768994A2 Cyclic peptide antibiotics |
| 04/04/2007 | EP1768698A2 Immunogenic compositions comprising hmgb1 polypeptides |
| 04/04/2007 | EP1768688A2 Oral vaccine for borrelia |
| 04/04/2007 | EP1472286B1 Production process of recombinant placental growth factor |
| 04/04/2007 | EP1443054B1 Anitmicrobial proteins, genes encoding the proteins and mehtod of using the same |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1282704B1 Cng3b: a novel cyclic nucleotide-gated cation channel |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1226256B1 Recombinant bifunctional fusion proteins for the clearance of variable viruses |
| 04/04/2007 | EP0981631B1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | EP0871718B1 Production of enzymatically active recombinant carboxypeptidase b |
| 04/04/2007 | CN1942767A Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose |
| 04/04/2007 | CN1942589A Modified human interferon polypeptides and their uses |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942582A Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 04/04/2007 | CN1942581A Antibody with osteoclast-related protein as target |
| 04/04/2007 | CN1942579A Site-specific incorporation of redox active amino acids into proteins |
| 04/04/2007 | CN1940084A Production of brewing yeast mannose protein of wine additive |
| 04/04/2007 | CN1940072A Antiglyphosate gene and its use |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1940067A Promoters for expressing genes in a fungal cell |
| 04/04/2007 | CN1940059A Fermentation of FW523 series compound from marine single-cell FIMO2-523 |
| 04/04/2007 | CN1308459C Process for producing casein peptide using coarse cheese as raw material |
| 04/04/2007 | CN1308458C Method for expressing human recombined interleukin 18 (rhIL-18) through yeast as well as product |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308449C Carrier and engineering bacteria for expressing extremehalophile purple membrane |
| 04/04/2007 | CN1308444C Method for purifying large quqntitics of fermentation liquid of gene recombined alpha galactosidase |
| 04/04/2007 | CN1308435C Laccase, preparing method thereof and strain special for same |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308346C Novel human phosphotidylethanolamine binding protein, its coding sequence and application |
| 04/03/2007 | USRE39548 Interleukin-5 specific recombinant antibodies |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199230 Isolated from Streptomyces cinnamoneus; used to make lantibiotic duramycin; producing the preduramycin, produramycin or mature duramycin peptides |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199222 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198942 Acetylcholine receptor subunits |
| 04/03/2007 | US7198938 Morphological mutants of filamentous fungi |
| 04/03/2007 | US7198937 oleaginous yeast that accumulates oils enriched in long-chain omega -3 and/or omega -6 polyunsaturated fatty acids; comprises chimeric nucleic acid molecule encoding a diacylglycerol acyltransferase 2 enzyme |
| 04/03/2007 | US7198933 Comprises enzymatic protein for conversion of glucose to fructose; food processing; high fructose corn syrup |
| 04/03/2007 | US7198932 Gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene derived from arabidopsis thaliana |
| 04/03/2007 | US7198929 Nucleotide sequences coding eukaryotic initiation factor-2 kinase for use in the identification of modulators which prevent and treat viral and liver disorders |
| 04/03/2007 | US7198928 Human COX-1 alternatively spliced variants and methods of using same |
| 04/03/2007 | US7198921 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby |
| 04/03/2007 | US7198920 HER-2/neu fusion proteins |
| 04/03/2007 | US7198919 recombinant DNA technology utilizing yeast host systems and expression vehicles that produce, process and secrete heterologous protein as discrete product; heterologous protein is selected from the interferon, serum albumin, tissue plasminogen activator, rennin and insulin-like growth factor |
| 04/03/2007 | US7198916 Nucleotide sequences coding mutated fluorescent protein for use as improved diagnostic indicator in genetic engineering |
| 04/03/2007 | US7198915 Preparing modified/artificial polypeptides; mimetics |
| 04/03/2007 | US7198914 Comprises nucleotide sequences coding g protein coupled receptor for identifying modulator for treatment and prevention of cardiovascular, respiratory, muscle, liver, gastrointestinal, urogenital and blood disorders |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198912 Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39 |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198909 Myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 04/03/2007 | US7198896 Immunoaffinity isolation of modified peptides from complex mixtures |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198787 Preferentially kill mammary gland cancer cells; obtain cells, exposed to mixture of toxins, monitor cellular response to toxins |
| 04/03/2007 | US7198781 Chimeric interleukin-6 soluble receptor/ligand proteins |
| 04/03/2007 | CA2236679C Differentiation-suppressive polypeptide |
| 04/03/2007 | CA2176943C Mutants of bone morphogenetic proteins |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 04/03/2007 | CA2121559C Immunogenic artificial polypeptide |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 04/03/2007 | CA2103195C Method for the production of proteins in plant fluids |
| 04/03/2007 | CA2094495C Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates |
| 04/03/2007 | CA2089661C Transgenic non-human animals capable of producing heterologous antibodies |
| 04/03/2007 | CA1341524C Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid ti plasmid vectors useful for this process |